Search results
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says
Quartz· 15 hours agoIt may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity...
Dow Jones Futures: Dow, S&P 500, Nasdaq Hit Highs, Nvidia Leads 12 New Buys; What To Do Now
Investor's Business Daily· 54 minutes agoNvidia, the market's most important stock, broke out past a buy point a week before earnings. Dell...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 9 hours agoEli Lilly stock yo-yoed recently after announcing the Food and Drug Administration has scheduled an...
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks via Yahoo Finance· 10 hours agoEli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and...
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
Benzinga via Yahoo Finance· 8 hours agoEli Lilly And Co (NYSE:LLY) has reportedly reached a settlement agreement with a medi spa that sold...
How Are Eli Lilly’s Profit Margins Trending?
Forbes· 19 hours agoEli Lilly (NYSE: LLY) saw its net income decline by $1 billion or 16% y-o-y to $5.2 billion in 2023. This can primarily be attributed to higher acquired...
These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now | The Motley Fool
The Motley Fool· 15 hours agoShares of Eli Lilly (LLY 2.53%) are up by a shocking 309% over the last three years, and, as smart...
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
The Wall Street Journal· 1 day agoEli Lilly has reached its first legal settlement with one of the spas that it had accused in...
Is Eli Lilly Stock A Better Pick Over Amgen?
Forbes· 3 days agoAlso, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the comparison, and in the sections below, we discuss why we...
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
Morningstar· 2 days agoWith strong pricing power and sales growth of key drugs, here’s what we think of Lilly’s stock. Eli ...